000 | 01300 a2200337 4500 | ||
---|---|---|---|
005 | 20250517034713.0 | ||
264 | 0 | _c20160926 | |
008 | 201609s 0 0 eng d | ||
022 | _a1940-4034 | ||
024 | 7 |
_a10.1177/1074248415590196 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSleder, Anna T | |
245 | 0 | 0 |
_aCardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology and therapeutics _cJan 2016 |
||
300 |
_a20-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
650 | 0 | 4 |
_aBiotransformation _xgenetics |
650 | 0 | 4 |
_aCardiovascular Agents _xadverse effects |
650 | 0 | 4 |
_aCardiovascular Diseases _xdiagnosis |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xgenetics |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aKalus, James | |
700 | 1 | _aLanfear, David E | |
773 | 0 |
_tJournal of cardiovascular pharmacology and therapeutics _gvol. 21 _gno. 1 _gp. 20-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1074248415590196 _zAvailable from publisher's website |
999 |
_c24963022 _d24963022 |